157 related articles for article (PubMed ID: 1674512)
41. Distribution of proline-specific aminopeptidases in human tissues and body fluids.
Vanhoof G; De Meester I; van Sande M; Scharpé S; Yaron A
Eur J Clin Chem Clin Biochem; 1992 Jun; 30(6):333-8. PubMed ID: 1380841
[TBL] [Abstract][Full Text] [Related]
42. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
[TBL] [Abstract][Full Text] [Related]
43. Proteolytic enzymes in bronchopulmonary lavage fluids: cathepsin B-like activity and prolyl endopeptidase.
Orlowski M; Orlowski J; Lesser M; Kilburn KH
J Lab Clin Med; 1981 Apr; 97(4):467-76. PubMed ID: 7009773
[TBL] [Abstract][Full Text] [Related]
44. Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.
Demuth HU; Schlenzig D; Schierhorn A; Grosche G; Chapot-Chartier MP; Gripon JC
FEBS Lett; 1993 Mar; 320(1):23-7. PubMed ID: 8096464
[TBL] [Abstract][Full Text] [Related]
45. Alteration in dipeptidyl peptidase activities in cultured human carcinoma cells.
Komatsu M; Urade M; Yamaoka M; Fukasawa K; Harada M
J Natl Cancer Inst; 1987 May; 78(5):863-8. PubMed ID: 2883339
[TBL] [Abstract][Full Text] [Related]
46. The effect of inhibitors of prolyl endopeptidase and pyroglutamyl peptide hydrolase on TRH degradation in rat serum.
Friedman TC; Wilk S
Biochem Biophys Res Commun; 1985 Oct; 132(2):787-94. PubMed ID: 2865955
[TBL] [Abstract][Full Text] [Related]
47. A kinetic fluorometric assay of dipeptidyl peptidase IV in viable human blood mononuclear cells.
Sedo A; Krepela E; Kasafírek E
Biochimie; 1989 Jun; 71(6):757-61. PubMed ID: 2568856
[TBL] [Abstract][Full Text] [Related]
48. Dipeptidyl peptidase IV as a new surface marker for a subpopulation of human T-lymphocytes.
Mentlein R; Heymann E; Scholz W; Feller AC; Flad HD
Cell Immunol; 1984 Nov; 89(1):11-9. PubMed ID: 6386188
[TBL] [Abstract][Full Text] [Related]
49. Activity and tissue localization of cathepsin G in non small cell lung cancer.
Maksimowicz T; Chyczewska E; Chyczewski L; Nikliński J; Ostrowska H; Szyszko J; Furman M
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():199-216. PubMed ID: 9337538
[TBL] [Abstract][Full Text] [Related]
50. An evaluation of the role of a pyroglutamyl peptidase, a post-proline cleaving enzyme and a post-proline dipeptidyl amino peptidase, each purified from the soluble fraction of guinea-pig brain, in the degradation of thyroliberin in vitro.
Browne P; O'Cuinn G
Eur J Biochem; 1983 Dec; 137(1-2):75-87. PubMed ID: 6140164
[TBL] [Abstract][Full Text] [Related]
51. In situ identification and enumeration of helper T lymphocytes in cutaneous malignant lymphomas by dipeptidyl-peptidase IV (DPP IV).
Sterry W; Steigleder GK; Goos M; Meisterernst E
J Cutan Pathol; 1982 Apr; 9(2):119-20. PubMed ID: 7047598
[No Abstract] [Full Text] [Related]
52. Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidyl peptidase IV-like activities in gingival crevicular fluid: a comparison of levels before and after periodontal surgery in chronic periodontitis patients.
Eley BM; Cox SW
J Periodontol; 1992 May; 63(5):412-7. PubMed ID: 1356148
[TBL] [Abstract][Full Text] [Related]
53. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
[TBL] [Abstract][Full Text] [Related]
54. Proteases in human lenses and their possible significance.
Swanson AA; Davis RM; Meinhardt NC
Curr Eye Res; 1985 Jan; 4(1):43-8. PubMed ID: 2858361
[TBL] [Abstract][Full Text] [Related]
55. Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis.
Hagihara M; Ohhashi M; Nagatsu T
Clin Chem; 1987 Aug; 33(8):1463-5. PubMed ID: 2886236
[TBL] [Abstract][Full Text] [Related]
56. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
57. Comparative immunohistochemistry and histochemistry of dipeptidyl peptidase IV in rat organs during development.
Hartel-Schenk S; Gossrau R; Reutter W
Histochem J; 1990 Oct; 22(10):567-78. PubMed ID: 1981214
[TBL] [Abstract][Full Text] [Related]
58. Demonstration of proteases in basal cell carcinomas. A histochemical study using amino acid-4-methoxy-2-naphthylamides as chromogenic substrates.
Schlagenhauff B; Klessen C; Teichmann-Dörr S; Breuninger H; Rassner G
Cancer; 1992 Sep; 70(5):1133-40. PubMed ID: 1355397
[TBL] [Abstract][Full Text] [Related]
59. Studies on the regulation of X-prolyl dipeptidyl aminopeptidase activity.
Garcia Ramos C; Cruz Camarillo R; Gascon S; Suárez Rendueles MP
J Gen Microbiol; 1983 Nov; 129(11):3519-23. PubMed ID: 6141215
[TBL] [Abstract][Full Text] [Related]
60. Activity of lysosomal and nonlysosomal proteases of fibrosarcoma induced by methylcholanthrene.
Gołaszewski Z; Sobolewski K; Gołaszewska J; Pałka J; Ostrowska H
Rocz Akad Med Bialymst; 1997; 42(1):213-7. PubMed ID: 9581482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
